RxDoctor Payments Data

Alon Antebi, DO

Orthopaedic Trauma · Lancaster, CANPI 1639174816

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Arthrex at 32.6% of the total. Reporting peaked in 2021 at $47,047 and has fallen 88.7% since, to $5,338 in 2025.

$142,960in general payments, 2019–2025

Across 125 payments — averaging $1143.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$47K
  • Advanced Orthopaedic Solutions, Inc.$41K
  • US Implant Solutions, LLC$18K
  • Mimedx Group, Inc.$14K
  • Maxx Health Inc$9K
  • Aap Implants Inc$4K
  • plus $10K from 21 others
$603,861in research payments, 2019–2025

Across 9 payments — averaging $67,096 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$604K

What the payments were for

  • Consulting fees$64,75045%
  • Speaking & faculty fees$47,61033%
  • Travel & lodging$18,41213%
  • Food & beverage$8,5886%
  • Education$3,6003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex4$46,600
Advanced Orthopaedic Solutions, Inc.5$41,050
US Implant Solutions, LLC30$18,365
Mimedx Group, Inc.3$14,071
Maxx Health Inc12$9,481
Aap Implants Inc1$3,535
Smith+Nephew21$3,397
Maxx Orthopedics, Inc.2$2,465
Encore Medical, LP4$643
Zimmer Biomet7$553
Medtronic5$411
Avanos Medical4$401
Stryker8$397
Tracpatch Health, Inc1$354
Lima USA, Inc.2$290
Vertos Medical, Inc.2$257
Spinal Elements, Inc.1$150
Nevro Corp.3$135
Imbed Biosciences Inc.1$112
Johnson & Johnson1$72
Osteoremedies, LLC1$71
Boston Scientific1$58
BD1$29
Vision Quest Industries Inc.2$28
Pacira Pharmaceuticals Incorporated1$15
Acell, Inc.1$14
Heron Therapeutics, Inc.1$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,960 in reported general payments places this provider in the 85th percentile of 106 orthopaedic trauma providers in California.

See all orthopaedic trauma providers in California

Medicare billing

Part B allowed, 2024
$399,098
Medicare patients
552
Services billed
3,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen230$2,301
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen80$735
Meloxicam54$224
Diclofenac Sodium14$192
Acetaminophen-CodeineAcetaminophen With Codeine23$180
Tramadol Hcl32$117
Ibuprofen22$109
Methylprednisolone19$109
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim28$105

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Lancaster

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →